These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 29920743)

  • 1. Identification of a crucial tryptophan residue in ADAMTS13 required for its secretion and enzymatic activity.
    Ling J; Ma Z; Liu L; Yin J; Su J; Shen F; Xie L; Hu S
    Clin Exp Pharmacol Physiol; 2018 Nov; 45(11):1181-1186. PubMed ID: 29920743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tryptophan 387 and 390 residues in ADAMTS13 are crucial to the ability of vascular tube formation and cell migration of endothelial cells.
    Liu L; Ma Z; Zhou X; Yin J; Lu J; Su J; Shen F; Xie L; Hu S; Ling J
    Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1402-1409. PubMed ID: 32222985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The WXXW motif in the TSR1 of ADAMTS13 is important for its secretion and proteolytic activity.
    Ling J; Su J; Ma Z; Ruan C
    Thromb Res; 2013 Jun; 131(6):529-34. PubMed ID: 23683325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic and Functional Characterization of ADAMTS13 Variants in a Patient Cohort with Upshaw-Schulman Syndrome Investigated in Germany.
    Hassenpflug WA; Obser T; Bode J; Oyen F; Budde U; Schneppenheim S; Schneppenheim R; Brehm MA
    Thromb Haemost; 2018 Apr; 118(4):709-722. PubMed ID: 29554699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the "minimal" structure of a functional ADAMTS13 by mutagenesis and small-angle X-ray scattering.
    Zhu J; Muia J; Gupta G; Westfield LA; Vanhoorelbeke K; Tolia NH; Sadler JE
    Blood; 2019 Apr; 133(17):1909-1918. PubMed ID: 30692120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological Function of CysR Domain of ADAMTS13].
    Wu H; Li H; Su C; Li HY; Cui RH; Jin SY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):893-900. PubMed ID: 34105490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human neutrophil peptides inhibit cleavage of von Willebrand factor by ADAMTS13: a potential link of inflammation to TTP.
    Pillai VG; Bao J; Zander CB; McDaniel JK; Chetty PS; Seeholzer SH; Bdeir K; Cines DB; Zheng XL
    Blood; 2016 Jul; 128(1):110-9. PubMed ID: 27207796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic inactivation of ADAMTS13 by plasmin in human plasma: risk of thrombotic thrombocytopenic purpura.
    Shin Y; Miyake H; Togashi K; Hiratsuka R; Endou-Ohnishi K; Imamura Y
    J Biochem; 2018 May; 163(5):381-389. PubMed ID: 29228282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin cleavage of von Willebrand factor as an emergency bypass for ADAMTS13 deficiency in thrombotic microangiopathy.
    Tersteeg C; de Maat S; De Meyer SF; Smeets MW; Barendrecht AD; Roest M; Pasterkamp G; Fijnheer R; Vanhoorelbeke K; de Groot PG; Maas C
    Circulation; 2014 Mar; 129(12):1320-31. PubMed ID: 24449821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Domain-specific mechanical modulation of VWF-ADAMTS13 interaction.
    Li Z; Lin J; Sulchek T; Cruz MA; Wu J; Dong JF; Zhu C
    Mol Biol Cell; 2019 Jul; 30(16):1920-1929. PubMed ID: 31067148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13 haplotype on coronary artery disease.
    Lasom S; Komanasin N; Settasatian N; Settasatian C; Kukongviriyapan U; Intharapetch P; Senthong V
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):286-294. PubMed ID: 27536857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update on ADAMTS13 and VWF in cardiovascular and hematological disorders.
    Akyol O; Akyol S; Chen CH
    Clin Chim Acta; 2016 Dec; 463():109-118. PubMed ID: 27746209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of spacer-α6 complex: a novel insight into binding of ADAMTS13 with A2 domain of von Willebrand factor under forces.
    Fang X; Lin J; Fang Y; Wu J
    Sci Rep; 2018 Apr; 8(1):5791. PubMed ID: 29636514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of cysteine thiol-based linkages in ADAMTS13 in support of a non-proteolytic regulation of von Willebrand factor.
    Rottensteiner H; Seyfried BK; Kaufmann S; Fiedler C; Dong JF; Zheng XL; Plaimauer B; Scheiflinger F
    J Thromb Haemost; 2019 Dec; 17(12):2099-2109. PubMed ID: 31393047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ADAMTS13, von Willebrand factor specific cleaving protease].
    Veyradier A; Coppo P
    Med Sci (Paris); 2011 Dec; 27(12):1097-105. PubMed ID: 22192749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential therapeutic benefit of targeting ADAMTS13 activity.
    Eerenberg ES; Levi M
    Semin Thromb Hemost; 2014 Feb; 40(1):28-33. PubMed ID: 24338607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Von Willebrand factor, ADAMTS-13, and thrombotic thrombocytopenic purpura.
    Zhou Z; Nguyen TC; Guchhait P; Dong JF
    Semin Thromb Hemost; 2010 Feb; 36(1):71-81. PubMed ID: 20391298
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Truncation of ADAMTS13 by Plasmin Enhances Its Activity in Plasma.
    Clark CC; Mebius MM; de Maat S; Tielens AGM; de Groot PG; Urbanus RT; Fijnheer R; Hazenberg BPC; van Hellemond JJ; Maas C
    Thromb Haemost; 2018 Mar; 118(3):471-479. PubMed ID: 29534248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Thrombotic Thrombocytopenic Purpura --Pathophysiology and Assays of ADAMTS13 Activity].
    Kato S; Fujimura Y
    Rinsho Byori; 2015 Oct; 63(10):1228-36. PubMed ID: 26897861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical utility of ADAMTS13 activity, antigen and autoantibody assays in thrombotic thrombocytopenic purpura.
    Starke R; Machin S; Scully M; Purdy G; Mackie I
    Br J Haematol; 2007 Feb; 136(4):649-55. PubMed ID: 17367414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.